Therapeutic implications of osteoprotegerin

<p>Abstract</p> <p>Osteoprotegerin (OPG), a member of the tumor necrosis factor (TNF) receptor superfamily, contributes determinatively to the bone remodeling as well as to the pathogenetic mechanism of bone malignancies and disorders of mineral metabolism. There is additional evid...

Full description

Bibliographic Details
Published in:	Cancer Cell International
Main Authors:	Karalaki Maria, Fili Sofia, Schaller Bernhard
Format:	Article
Language:	English
Published:	BMC 2009-09-01
Online Access:	http://www.cancerci.com/content/9/1/26

Similar Items

Osteoprotegerin in Cardiometabolic Disorders
by: C. Pérez de Ciriza, et al.
Published: (2015-01-01)

Osteoprotegerin mediates adipogenesis in obesity
by: Zipan Lyu, et al.
Published: (2024-08-01)

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females
by: Saba Tariq, et al.
Published: (2023-01-01)

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females.
by: Saba Tariq, et al.
Published: (2023-01-01)

Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
by: Areti Augoulea, et al.
Published: (2013-01-01)

Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
by: Dirk Geerts, et al.
Published: (2020-04-01)

Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.
by: Batmunkh Bumdelger, et al.
Published: (2016-01-01)

Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01)

RANKL/RANK/osteoprotegerin system as novel therapeutic target in the treatment of primary bone tumors and osteolytic metastases
by: Anđelković Zlatibor, et al.
Published: (2004-01-01)

Investigating the role of osteoprotegerin gene polymorphic variants in osteoporosis
by: Bulat I. Yalaev, et al.
Published: (2021-03-01)

Osteoprotegerin gene polymorphisms in postmenopausal women with knee osteoarthritis
by: Grigorii A. Ignatenko, et al.
Published: (2024-06-01)

Parathyroid Hormone on Osteoprotegerin Levels in Patients with Primary Hyperparathyroidism
by: Berna Okudan, et al.
Published: (2022-10-01)

Osteoprotegerin in infection-induced acute inflammatory states in children
by: Aristeidis Giannakopoulos, et al.
Published: (2024-03-01)

Value of serum osteoprotegerin in the assessment of endothelial dysfunction in obesity
by: Ahmed Mohammed Shennawy, et al.
Published: (2024-04-01)

OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015-04-01)

Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation
by: WANG Xin, et al.
Published: (2013-10-01)

The role of osteoprotegerin (OPG) in exercise-induced skeletal muscle adaptation
by: Owens Aaron, et al.
Published: (2024-12-01)

A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
by: Curl Linda, et al.
Published: (2012-11-01)

In vitro evaluation of osteoprotegerin in chitosan for potential bone defect applications
by: Soher Nagi Jayash, et al.
Published: (2016-08-01)

Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
by: Filip Przerwa, et al.
Published: (2023-12-01)

The roles of osteoprotegerin in cancer, far beyond a bone player
by: Yufei Wang, et al.
Published: (2022-05-01)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
by: Yen-Liang Chen, et al.
Published: (2023-10-01)

Osteoprotegerin, sclerostin, and osteocalcin serum levels in thyroid disorder patients
by: F. F. Rija, et al.
Published: (2021-10-01)

Osteoprotegerin Induces CD34+ Differentiation in Endothelial Progenitor Cells
by: Catherine Boisson-Vidal, et al.
Published: (2018-11-01)

Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
by: Stella Bernardi, et al.
Published: (2017-07-01)

The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
by: Migacz Maciej, et al.
Published: (2020-05-01)

THE ROLE OF OSTEOPROTEGERIN SYSTEM /RANKL/RANK IN PATHOGENESIS OF AORTIC STENOSIS
by: O. B. Irtyuga, et al.
Published: (2018-03-01)

Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.
by: Alberto Benito-Martin, et al.
Published: (2013-01-01)

Serum level of osteoprotegerin in patients with Parkinson’s disease: a preliminary study
by: Marta Piaścik-Gromada, et al.
Published: (2024-03-01)

Angiotensin II Induces Aortic Rupture and Dissection in Osteoprotegerin‐Deficient Mice
by: Toshihiro Tsuruda, et al.
Published: (2022-04-01)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
by: Guanghao Chi, et al.
Published: (2023-11-01)

Osteoprotegerin Gene Polymorphisms Are Associated with Subclinical Atherosclerosis in the Mexican Mestizo Population
by: Benny Giovanni Cazarín-Santos, et al.
Published: (2022-06-01)

Osteoprotegerin Expression in Liver is Induced by IL13 through TGFβ
by: Adhyatmika Adhyatmika, et al.
Published: (2022-01-01)

Osteoprotegerin as an Early Sign of Chronic Kidney Disease-Mineral and Bone Disorder
by: Antun Gršković, et al.
Published: (2023-01-01)

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
by: Winther Kaj, et al.
Published: (2011-07-01)

Association of osteoprotegerin and rankl levels with insulin resistance in pubertal obese children
by: Yeşilkaya Ediz, et al.
Published: (2010-04-01)

Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
by: Aoki Atsushi, et al.
Published: (2013-01-01)

Value of osteoprotegerin, RANKL, interleukin-17 in mechanisms of bone metabolism disorders
by: V. F. Cheremisina
Published: (2017-07-01)

Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus
by: Binbin Huang, et al.
Published: (2020-09-01)

Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease
by: E A Kochetkova, et al.
Published: (2010-08-01)